Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee
David W Ellison, Olabisi E Onilude, Janet C Lindsey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2011
Rapid diagnosis of medulloblastoma molecular subgroups
Ed C Schwalbe, Janet C Lindsey, Debbie Straughton, et al.
Neuro-Oncology
|
October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study
Edward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
The Lancet. Child & Adolescent Health
|
November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study
Rebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Neuropathology and Applied Neurobiology
|
April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics
Stephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
Acta Neuropathologica
|
January 8, 2013
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C Schwalbe, Daniel Williamson, Janet C Lindsey, et al.
Cell Reports
|
August 4, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
Daniel Williamson, Edward C Schwalbe, Debbie Hicks, et al.
The Lancet. Oncology
|
May 27, 2017
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, et al.
Neuro-Oncology
|
October 8, 2024
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma
Magretta Adiamah, Bethany Poole, Janet C Lindsey, et al.
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee
David W Ellison, Olabisi E Onilude, Janet C Lindsey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2011
Rapid diagnosis of medulloblastoma molecular subgroups
Ed C Schwalbe, Janet C Lindsey, Debbie Straughton, et al.
Neuro-Oncology
|
October 8, 2024
Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study
Edward C Schwalbe, Janet C Lindsey, Marina Danilenko, et al.
The Lancet. Child & Adolescent Health
|
November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study
Rebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
Neuropathology and Applied Neurobiology
|
April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics
Stephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
Acta Neuropathologica
|
January 8, 2013
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C Schwalbe, Daniel Williamson, Janet C Lindsey, et al.
Cell Reports
|
August 4, 2022
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
Daniel Williamson, Edward C Schwalbe, Debbie Hicks, et al.
The Lancet. Oncology
|
May 27, 2017
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, et al.
Neuro-Oncology
|
October 8, 2024
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma
Magretta Adiamah, Bethany Poole, Janet C Lindsey, et al.
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Page
of 3